🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Immunome, Inc.

IMNM Healthcare
$21.83 $-0.71 (-3.15%)
Market Cap: $2.47 B
Gurus Holding
4
Popularity Rank
#2384
% of Shares Held
1.11%
Net Activity (Q1 2026)
-$167.55 M

Guru Ownership Trend

Guru Analysis for Immunome, Inc. (IMNM)

Immunome, Inc. (IMNM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.47 M.

Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bearish. This is evidenced by a $167.55 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Jefferies Group reduced exposure by 42.0%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$1.92 M
Total Buy Value
New Buys 2
Additions 0
-$169.47 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Immunome, Inc. (IMNM)

Major holders include Jefferies Group ($25.38 M), Renaissance Technologies (RenTech) ($1.51 M), Cliff Asness ($409,582). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.26 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $167.55 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited IMNM. The total reported sell value was $169.47 M.

Yes, 2 managers opened new positions in IMNM, and 0 increased their existing holdings. The total reported buy value was $1.92 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.17% Reduce -42.0% 1,160,715 $25.38 M Q1 2026
0.00% New Buy 68,902 $1.51 M Q1 2026
0.00% New Buy 18,728 $409,582 Q1 2026
0.00% 10,100 $220,887 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form